Literature DB >> 9208937

Role of Tyr518 and Tyr519 in the regulation of catalytic activity and substrate phosphorylation by Syk protein-tyrosine kinase.

C Couture1, S Williams, N Gauthier, P Tailor, T Mustelin.   

Abstract

The Syk protein-tyrosine kinase is expressed in many hematopoietic cells and is involved in signaling from various receptors for antigen and Fc portions of IgG and IgE. After cross-linking of these receptors, Syk is rapidly phosphorylated on tyrosine residues. We have previously reported that Syk expressed in COS cells is predominantly phosphorylated at both Tyr518 and Tyr519 at its putative autophosphorylation site. In this study, we have examined the role of each of these two residues for the catalytic activity of Syk in vitro and for the Syk-induced phosphorylation of cellular proteins in intact cells. Mutation of either residue had minor effects on the catalytic activity of Syk, and even the double mutant [F518, F519]Syk was about 60% as active as the wild-type enzyme. In intact cells, however, all three mutants consistently failed to induce the extensive tyrosine phosphorylation of cellular proteins typically observed with wild-type Syk. We have recently shown that the doubly phosphorylated Y518/Y519 site is also the site for association of Syk with the SH2 domain of the Lck kinase, which suggests that although phosphates at Y518/Y519 may enhance the catalytic activity of Syk, its interaction with Src family protein-tyrosine kinases is at least equally important for the induction of downstream substrate phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9208937     DOI: 10.1111/j.1432-1033.1997.00447.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism.

Authors:  My S Mansueto; Abigail Reens; Larissa Rakhilina; An Chi; Bo-Sheng Pan; J Richard Miller
Journal:  J Biol Chem       Date:  2019-03-28       Impact factor: 5.157

2.  Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells.

Authors:  Juan Zhang; Elsa Berenstein; Reuben P Siraganian
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk.

Authors:  Kevin Reppschläger; Jeanne Gosselin; Carol A Dangelmaier; Dafydd H Thomas; Nick Carpino; Steven E McKenzie; Satya P Kunapuli; Alexander Y Tsygankov
Journal:  J Biol Chem       Date:  2016-09-08       Impact factor: 5.157

4.  A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn.

Authors:  Dipak Barua; William S Hlavacek; Tomasz Lipniacki
Journal:  J Immunol       Date:  2012-06-18       Impact factor: 5.422

5.  Go6976 abrogates GPVI-mediated platelet functional responses in human platelets through inhibition of Syk.

Authors:  T M Getz; A Mayanglambam; J L Daniel; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

6.  Regulation of Syk by phosphorylation on serine in the linker insert.

Authors:  Leela L Paris; Jianjie Hu; Jacob Galan; Su Sien Ong; Victoria A Martin; Haiyan Ma; W Andy Tao; Marietta L Harrison; Robert L Geahlen
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

7.  The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.

Authors:  Sue Rigby; Yuanxue Huang; Berthold Streubel; Andreas Chott; Ming-Qing Du; Suzanne D Turner; Chris M Bacon
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

Review 8.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

9.  TULA-2 Deficiency Enhances Platelet Functional Responses to CLEC-2 Agonists.

Authors:  John C Kostyak; Benjamin R Mauri; Carol Dangelmaier; Akruti Patel; Yuhang Zhou; Johannes A Eble; Alexander Y Tsygankov; Steven E McKenzie; Satya P Kunapuli
Journal:  TH Open       Date:  2018-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.